New assays reflect growth in company's customized primary human cell biology contract research business
SEATTLE, March 18, 2015 /PRNewswire/ — ReachBio Research Labs (http://www.reachbio.com), a Seattle-based contract research company specializing in primary cell biology, announced today the roll-out of a platform of immunology-based assays and the hiring of an experienced scientific manager for its new immunology services.
Logo – http://photos.prnewswire.com/prnh/20150317/182737LOGO
Dr. Galina Strizheva, MD, ReachBio's new Immunology Division Manager, was previously the manager of the immunology department of Eurofins Panlabs (Redmond, WA). "Dr. Strizheva comes to ReachBio with a wealth of experience in immunology, cell biology and client management," says Dr. Emer Clarke, ReachBio's Chief Scientific Officer. "The timing of her addition to our scientific team couldn't be better as we have experienced a considerable increase in client interest in relevant and predictive immunological assays utilizing primary human cells to help inform their development of new immunotherapeutics and other biologics."
According to Rob Chaney, ReachBio Research Labs' General Manager and Chief Operations Officer, the company's new immunology services address a number of areas of concern related to the development of biologics-based therapies for a variety of cancers and inflammatory diseases. "Our new immunology services platform includes assays for cytokine storms and cytokine release syndrome (CRS), cancer immunotherapy functional assays (e.g. ADCC), toll-like receptor (TLR) assays, inflammation models and more. These new immunology offerings are a natural outgrowth of our core expertise in hematopoietic stem and progenitor cell biology, cancer stem cell biology and other areas of primary cell biology and complement them nicely. Our growing strength in immunology also adds to our historical expertise in related areas such as flow cytometry, cytokine and mimetic evaluation, molecular biology and primary cell bank generation."
About ReachBio
ReachBio Research Labs (a trade name of ReachBio LLC) provides specialized contract research services and primary cell biology research tools to the drug development and life science research communities worldwide.
ReachBio Research Labs
123 NW 36th St., Suite 235
Seattle, WA 98107
Contact:
Rob Chaney
Tel: 206-420-0307
Email
www.reachbio.com